ChemPartner Adds B Cell Discovery from Berkeley Lights to Offerings

22:24 EDT 17 May 2019 | ChinaBio Today

Shanghai ChemPartner, a China CRO, extended its collaboration with Berkeley Lights Inc. of South San Francisco by installing BLI's Beacon® Optofluidic platform to offer B Cell antibody discovery services to its clients. ChemPartner will combine BLI's antibody discovery workflow for B cells with ChemPartner's assays. The Beacon® platform can screen tens of thousands of plasma B cells or gene-edited cells automatically, speeding up a usually time-consuming process. The Beacon® platform enables plasma B cell characterization in less than a day. More details....

Share this with colleagues:

Original Article: ChemPartner Adds B Cell Discovery from Berkeley Lights to Offerings


More From BioPortfolio on "ChemPartner Adds B Cell Discovery from Berkeley Lights to Offerings"

Quick Search


Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...